
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Implementation of a Vancomycin Dose-Optimization Protocol in Neonates: Impact on Vancomycin Exposure, Biological Parameters, and Clinical Outcomes - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDED16B88AE63F312D16B004880059E.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="aac">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9112885/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Antimicrobial Agents and Chemotherapy">
<meta name="citation_title" content="Implementation of a Vancomycin Dose-Optimization Protocol in Neonates: Impact on Vancomycin Exposure, Biological Parameters, and Clinical Outcomes">
<meta name="citation_author" content="Laura Gomez">
<meta name="citation_author_institution" content="Laboratory of Pharmacology, Pharmacogenetics, and Toxicology, Grenoble Alpes University Hospital, La Tronche, France">
<meta name="citation_author" content="Diane Boegler">
<meta name="citation_author_institution" content="Neonatal Intensive Care Unit, Grenoble Alpes University Hospital, La Tronche, France">
<meta name="citation_author" content="Chloé Epiard">
<meta name="citation_author_institution" content="Neonatal Intensive Care Unit, Grenoble Alpes University Hospital, La Tronche, France">
<meta name="citation_author" content="Layli Alin">
<meta name="citation_author_institution" content="Neonatal Intensive Care Unit, Grenoble Alpes University Hospital, La Tronche, France">
<meta name="citation_author" content="Julie Arata-Bardet">
<meta name="citation_author_institution" content="Pediatric Infectiology, Pediatrics Department, Grenoble Alpes University Hospital, La Tronche, France">
<meta name="citation_author" content="Yvan Caspar">
<meta name="citation_author_institution" content="Laboratory of Bacteriology, Grenoble Alpes University Hospital, La Tronche, France">
<meta name="citation_author_institution" content="University of Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France">
<meta name="citation_author" content="Thierry Debillon">
<meta name="citation_author_institution" content="Neonatal Intensive Care Unit, Grenoble Alpes University Hospital, La Tronche, France">
<meta name="citation_author_institution" content="University of Grenoble Alpes, TIMC, MESP Team, La Tronche, France">
<meta name="citation_author" content="Françoise Stanke-Labesque">
<meta name="citation_author_institution" content="Laboratory of Pharmacology, Pharmacogenetics, and Toxicology, Grenoble Alpes University Hospital, La Tronche, France">
<meta name="citation_author_institution" content="INSERM 1300, CHU Grenoble Alpes, University of Grenoble Alpes, Grenoble, France">
<meta name="citation_author" content="Elodie Gautier-Veyret">
<meta name="citation_author_institution" content="Laboratory of Pharmacology, Pharmacogenetics, and Toxicology, Grenoble Alpes University Hospital, La Tronche, France">
<meta name="citation_author_institution" content="INSERM 1300, CHU Grenoble Alpes, University of Grenoble Alpes, Grenoble, France">
<meta name="citation_publication_date" content="2022 Apr 25">
<meta name="citation_volume" content="66">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="e02191-21">
<meta name="citation_doi" content="10.1128/aac.02191-21">
<meta name="citation_pmid" content="35465728">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9112885/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9112885/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9112885/pdf/aac.02191-21.pdf">
<meta name="description" content="Vancomycin dosing used in neonates results frequently in insufficient concentrations. A vancomycin dose-optimization protocol consisting of an individualization of loading and maintenance doses (administered during continuous infusion) through a ...">
<meta name="og:title" content="Implementation of a Vancomycin Dose-Optimization Protocol in Neonates: Impact on Vancomycin Exposure, Biological Parameters, and Clinical Outcomes">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Vancomycin dosing used in neonates results frequently in insufficient concentrations. A vancomycin dose-optimization protocol consisting of an individualization of loading and maintenance doses (administered during continuous infusion) through a ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9112885/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9112885">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1128/aac.02191-21"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/aac.02191-21.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9112885%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9112885/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9112885/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9112885/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-aac.png" alt="Antimicrobial Agents and Chemotherapy logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Antimicrobial Agents and Chemotherapy" title="Link to Antimicrobial Agents and Chemotherapy" shape="default" href="https://journals.asm.org/journal/aac" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Antimicrob Agents Chemother</button></div>. 2022 Apr 25;66(5):e02191-21. doi: <a href="https://doi.org/10.1128/aac.02191-21" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1128/aac.02191-21</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Antimicrob%20Agents%20Chemother%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Antimicrob%20Agents%20Chemother%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Antimicrob%20Agents%20Chemother%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Antimicrob%20Agents%20Chemother%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Implementation of a Vancomycin Dose-Optimization Protocol in Neonates: Impact on Vancomycin Exposure, Biological Parameters, and Clinical Outcomes</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gomez%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Laura Gomez</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Laura Gomez</span></h3>
<div class="p">
<sup>a</sup>Laboratory of Pharmacology, Pharmacogenetics, and Toxicology, Grenoble Alpes University Hospital, La Tronche, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gomez%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Laura Gomez</span></a>
</div>
</div>
<sup>a,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boegler%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Diane Boegler</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Diane Boegler</span></h3>
<div class="p">
<sup>b</sup>Neonatal Intensive Care Unit, Grenoble Alpes University Hospital, La Tronche, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boegler%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Diane Boegler</span></a>
</div>
</div>
<sup>b,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Epiard%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Chloé Epiard</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Chloé Epiard</span></h3>
<div class="p">
<sup>b</sup>Neonatal Intensive Care Unit, Grenoble Alpes University Hospital, La Tronche, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Epiard%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chloé Epiard</span></a>
</div>
</div>
<sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alin%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Layli Alin</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Layli Alin</span></h3>
<div class="p">
<sup>b</sup>Neonatal Intensive Care Unit, Grenoble Alpes University Hospital, La Tronche, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alin%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Layli Alin</span></a>
</div>
</div>
<sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arata-Bardet%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Julie Arata-Bardet</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Julie Arata-Bardet</span></h3>
<div class="p">
<sup>c</sup>Pediatric Infectiology, Pediatrics Department, Grenoble Alpes University Hospital, La Tronche, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arata-Bardet%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Julie Arata-Bardet</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caspar%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Yvan Caspar</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Yvan Caspar</span></h3>
<div class="p">
<sup>d</sup>Laboratory of Bacteriology, Grenoble Alpes University Hospital, La Tronche, France</div>
<div class="p">
<sup>e</sup>University of Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caspar%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yvan Caspar</span></a>
</div>
</div>
<sup>d,</sup><sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Debillon%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Thierry Debillon</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Thierry Debillon</span></h3>
<div class="p">
<sup>b</sup>Neonatal Intensive Care Unit, Grenoble Alpes University Hospital, La Tronche, France</div>
<div class="p">
<sup>f</sup>University of Grenoble Alpes, TIMC, MESP Team, La Tronche, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Debillon%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Thierry Debillon</span></a>
</div>
</div>
<sup>b,</sup><sup>f</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stanke-Labesque%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Françoise Stanke-Labesque</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Françoise Stanke-Labesque</span></h3>
<div class="p">
<sup>a</sup>Laboratory of Pharmacology, Pharmacogenetics, and Toxicology, Grenoble Alpes University Hospital, La Tronche, France</div>
<div class="p">
<sup>g</sup>INSERM 1300, CHU Grenoble Alpes, University of Grenoble Alpes, Grenoble, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stanke-Labesque%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Françoise Stanke-Labesque</span></a>
</div>
</div>
<sup>a,</sup><sup>g</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gautier-Veyret%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Elodie Gautier-Veyret</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Elodie Gautier-Veyret</span></h3>
<div class="p">
<sup>a</sup>Laboratory of Pharmacology, Pharmacogenetics, and Toxicology, Grenoble Alpes University Hospital, La Tronche, France</div>
<div class="p">
<sup>g</sup>INSERM 1300, CHU Grenoble Alpes, University of Grenoble Alpes, Grenoble, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gautier-Veyret%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elodie Gautier-Veyret</span></a>
</div>
</div>
<sup>a,</sup><sup>g,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>a</sup>Laboratory of Pharmacology, Pharmacogenetics, and Toxicology, Grenoble Alpes University Hospital, La Tronche, France</div>
<div id="aff2">
<sup>b</sup>Neonatal Intensive Care Unit, Grenoble Alpes University Hospital, La Tronche, France</div>
<div id="aff3">
<sup>c</sup>Pediatric Infectiology, Pediatrics Department, Grenoble Alpes University Hospital, La Tronche, France</div>
<div id="aff4">
<sup>d</sup>Laboratory of Bacteriology, Grenoble Alpes University Hospital, La Tronche, France</div>
<div id="aff5">
<sup>e</sup>University of Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France</div>
<div id="aff6">
<sup>f</sup>University of Grenoble Alpes, TIMC, MESP Team, La Tronche, France</div>
<div id="aff7">
<sup>g</sup>INSERM 1300, CHU Grenoble Alpes, University of Grenoble Alpes, Grenoble, France</div>
<div class="author-notes p">
<div class="fn" id="fn1">
<sup>#</sup><p class="display-inline">Laura Gomez and Diane Boegler contributed equally to this article. Author order was determined in order of decreasing seniority.</p>
</div>
<div class="fn" id="fn2"><p>The authors declare no conflict of interest.</p></div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Nov 15; Revision requested 2022 Jan 19; Accepted 2022 Apr 3; Collection date 2022 May.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2022 American Society for Microbiology.</div>
<p><a href="https://doi.org/10.1128/ASMCopyrightv2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">All Rights Reserved</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9112885  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35465728/" class="usa-link">35465728</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>Vancomycin dosing used in neonates results frequently in insufficient concentrations. A vancomycin dose-optimization protocol consisting of an individualization of loading and maintenance doses (administered during continuous infusion) through a previously validated pharmacokinetic model was implemented in our center. This monocenter retrospective study aimed to compare vancomycin average concentration (Cavg) in the therapeutic range (15 to 25 mg/L) and biological and clinical parameters before and after implementation of this protocol. A total of 60 and 59 courses of vancomycin treatment in 45 and 49 patients were analyzed in groups before and after implementation, respectively. Initial vancomycin Cavg were more frequently in the therapeutic range in the group after implementation (74.6% versus 28.3%, <em>P</em> &lt; 0.001), with 1.6-fold higher Cavg (20.3 [17.0–22.2] mg/L versus 12.9 [11.3–17.0] mg/L, <em>P</em> &lt; 0.001). Considering all Cavg during longitudinal therapeutic drug monitoring (TDM), the frequency of therapeutic Cavg was higher in the group after implementation (74.8% [<em>n</em> = 103] versus 31% [<em>n</em> = 116], <em>P</em> &lt; 0.001). The dose optimization protocol was also associated with a reduced time to obtain a negative blood culture (<em>P</em> &lt; 0.001) and fewer antibiotic switches (<em>P</em> = 0.025), without increasing the frequency of nephrotoxicity. Clinical outcomes also appeared to be improved, with less periventricular leukomalacia (<em>P</em> = 0.021), trended toward less respiratory instability (<em>P</em> = 0.15) and a shorter duration of vasoactive drug use (<em>P</em> = 0.18) for neonates receiving personalized doses of vancomycin. This personalized vancomycin dose protocol improves vancomycin exposure in neonates, with good safety, and suggests an improvement in biological and clinical outcomes.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>KEYWORDS:</strong> vancomycin, neonates, pharmacokinetics, therapeutic drug monitoring, model-informed precision dosing</p></section></section><section id="s1"><h2 class="pmc_sec_title">INTRODUCTION</h2>
<p>Neonates admitted to neonatal intensive care units are at increased risk of sepsis due to their immature immune function and the invasive care required, and it is still a source of morbidity and mortality. Vancomycin, a glycopeptide with bactericidal activity, is the first-line antibiotic for the treatment of such nosocomial infections, most often due to coagulase-negative staphylococci (<a href="#B1" class="usa-link" aria-describedby="B1">1</a><a href="#B2" class="usa-link" aria-describedby="B2">–</a><a href="#B3" class="usa-link" aria-describedby="B3">3</a>). However, this antibiotic exhibits high pharmacokinetic variability, especially in neonates, and a narrow therapeutic range, justifying therapeutic drug monitoring (TDM). Vancomycin plasma concentrations are very often insufficient in neonates, with proportions of subtherapeutic concentrations varying from 47 to 93%, depending on the study (<a href="#B4" class="usa-link" aria-describedby="B4">4</a><a href="#B5" class="usa-link" aria-describedby="B5">–</a><a href="#B8" class="usa-link" aria-describedby="B8">8</a>). In this context, approaches for vancomycin dose adjustment for neonates, most frequently based on pharmacokinetic models, have been proposed (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>, <a href="#B9" class="usa-link" aria-describedby="B9">9</a><a href="#B10" class="usa-link" aria-describedby="B10">–</a><a href="#B14" class="usa-link" aria-describedby="B14">14</a>). However, few such strategies have been implemented in routine care and/or validated by clinical studies (<a href="#B15" class="usa-link" aria-describedby="B15">15</a>, <a href="#B16" class="usa-link" aria-describedby="B16">16</a>), and the impact of these strategies on the clinical-biological evolution of neonates has never been evaluated.</p>
<p>The very frequent subtherapeutic vancomycin concentrations measured during continuous infusion (average concentration, Cavg) observed in the neonatal intensive care unit of the Grenoble Alpes University Hospital led to the implementation of a vancomycin dose-optimization protocol in routine care (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>). This change in practice motivated us to carry out a retrospective study, the primary objective of which was to compare the proportion of initial vancomycin Cavg in the therapeutic range of 15 to 25 mg/L before and after the implementation of this protocol. In addition, we also investigated the impact of this change in practice on biological parameters and clinical outcomes.</p></section><section id="s2"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="s2-1"><h3 class="pmc_sec_title">Study population.</h3>
<p>The scheme for patient selection is presented in <a href="#F1" class="usa-link">Fig. 1</a>. A total of 60 courses of vancomycin treatment for 45 patients and 59 for 49 patients were included in the before-implementation (before) and after-implementation (after) groups, respectively. Baseline characteristics of the patients are presented in <a href="#T1" class="usa-link">Table 1</a>. There were no significant differences between the two groups, although there was a tendency toward a younger postnatal age and more males in the after group.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">FIG 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9112885_aac.02191-21-f001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb38/9112885/9103f71ec57a/aac.02191-21-f001.jpg" loading="lazy" height="398" width="760" alt="FIG 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Study flow chart.</p></figcaption></figure><section class="tw xbox font-sm" id="T1"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Baseline characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
</colgroup>
<thead>
<tr>
<th rowspan="2" colspan="1">Factor</th>
<th colspan="2" rowspan="1">Data for:<a href="#T1F1" class="usa-link"><sup><em>a</em></sup></a><hr>
</th>
<th rowspan="2" colspan="1">
<em>P</em> value</th>
</tr>
<tr>
<th rowspan="1" colspan="1">Before group (<em>n</em> = 60)</th>
<th rowspan="1" colspan="1">After group (<em>n</em> = 59)</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Birth weight (g)</td>
<td rowspan="1" colspan="1">928 [678–2.320]</td>
<td rowspan="1" colspan="1">970 [785–2,373]</td>
<td rowspan="1" colspan="1">0.53</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Weight at initiation of treatment (g)</td>
<td rowspan="1" colspan="1">1.590 [908–2.853]</td>
<td rowspan="1" colspan="1">1,300 [930–2,725]</td>
<td rowspan="1" colspan="1">0.44</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Plasma creatinine level before treatment (μmol/L)</td>
<td rowspan="1" colspan="1">39.0 [25.8–59.8]</td>
<td rowspan="1" colspan="1">38.0 [27.5–54.0]</td>
<td rowspan="1" colspan="1">0.88</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Postnatal age at initiation of treatment (days)</td>
<td rowspan="1" colspan="1">15.5 [7.0–30.3]</td>
<td rowspan="1" colspan="1">11.0 [5.5–18.8]</td>
<td rowspan="1" colspan="1">0.066</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Sex</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Male</td>
<td rowspan="1" colspan="1">33 (55.0)</td>
<td rowspan="1" colspan="1">42 (71.2)</td>
<td rowspan="1" colspan="1">0.067</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Birth term (wks of amenorrhea)</td>
<td rowspan="1" colspan="1">29.4 [25.8–36.6]</td>
<td rowspan="1" colspan="1">28.3 [26.9–35.6]</td>
<td rowspan="1" colspan="1">0.79</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Gestational age (wks)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> ≥37</td>
<td rowspan="1" colspan="1">14 (23.3)</td>
<td rowspan="1" colspan="1">12 (20.3)</td>
<td rowspan="1" colspan="1">0.59</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> ≥32 and &lt;37</td>
<td rowspan="1" colspan="1">10 (16.7)</td>
<td rowspan="1" colspan="1">8 (13.6)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> ≥28 and &lt;32</td>
<td rowspan="1" colspan="1">10 (16.7)</td>
<td rowspan="1" colspan="1">16 (27.1)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> ≥24 and &lt;28</td>
<td rowspan="1" colspan="1">26 (43.3)</td>
<td rowspan="1" colspan="1">23 (39.0)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Antenatal corticotherapy</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Not indicated</td>
<td rowspan="1" colspan="1">19 (31.7)</td>
<td rowspan="1" colspan="1">15 (25.4)</td>
<td rowspan="1" colspan="1">0.48</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> None or incomplete</td>
<td rowspan="1" colspan="1">11 (18.3)</td>
<td rowspan="1" colspan="1">8 (13.6)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Complete treatment</td>
<td rowspan="1" colspan="1">30 (50.0)</td>
<td rowspan="1" colspan="1">36 (61.0)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Birth weight &lt; 10<sup>th</sup> percentile<a href="#T1F2" class="usa-link"><sup><em>b</em></sup></a>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Yes</td>
<td rowspan="1" colspan="1">17 (28.3)</td>
<td rowspan="1" colspan="1">12 (20.3)</td>
<td rowspan="1" colspan="1">0.31</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Catheter type</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> No catheter/peripheral venous catheter</td>
<td rowspan="1" colspan="1">5 (8.3)</td>
<td rowspan="1" colspan="1">9 (15.3)</td>
<td rowspan="1" colspan="1">0.65</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Umbilical venous catheter</td>
<td rowspan="1" colspan="1">9 (15)</td>
<td rowspan="1" colspan="1">10 (16.9)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Epicutaneous-cave catheter</td>
<td rowspan="1" colspan="1">36 (60)</td>
<td rowspan="1" colspan="1">32 (54.2)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Central venous catheter</td>
<td rowspan="1" colspan="1">10 (16.7)</td>
<td rowspan="1" colspan="1">8 (13.6)</td>
<td rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="T1F1">
<sup>a</sup><p class="display-inline">Data are reported as <em>n</em> (%) or medians [25<sup>th</sup> to 75<sup>th</sup> percentiles].</p>
</div>
<div class="fn" id="T1F2">
<sup>b</sup><p class="display-inline">The 10<sup>th</sup> percentile is defined by standardized growth curves according to gestational age and sex.</p>
</div>
</div></section><p>Infection was documented by the isolation of a microorganism from positive blood cultures for 52.5% of vancomycin cures for the before group and 40% for the after group. The proportion of bacterial or yeast species identified from blood cultures for the entire cohort is presented in Fig. S1 in the supplemental material. Among documented infections, 94.3% and 88.7% were due to Gram-positive bacteria and coagulase-negative staphylococci (of which 93.6% were resistant to methicillin), respectively. The median vancomycin MIC of isolated Gram-positive cocci did not differ between the two groups (before [<em>n</em> = 22] and after [<em>n</em> = 17], 1.0 [1.0–2.0] mg/L versus 1.0 [1.0–2.0] mg/L, <em>P</em> = 0.86), as well as the frequency of bacteria with a of MIC ≥2 mg/L (before and after, 43.5% versus 45.0%, <em>P</em> = 0.9).</p>
<p>Loading (before, 7.1 [7.0–7.1] mg/kg; after, 11.1 [10.3–11.6] mg/kg) and maintenance (before, 19.4 [12.1–28.4] mg/kg/d; after, 28.1 [22.4–35.7] mg/kg/d) doses (administered by continuous infusion) were significantly higher (<em>P</em> &lt; 0.001) for the after group, the increase being particularly large for the subgroup of extremely premature infants (<a href="#F2" class="usa-link">Fig. 2A</a> and <a href="#F2" class="usa-link">B</a>).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">FIG 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9112885_aac.02191-21-f002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb38/9112885/e6e36dc88e51/aac.02191-21-f002.jpg" loading="lazy" height="226" width="760" alt="FIG 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Vancomycin doses before and after implementation of the dose optimization protocol. (A) Loading doses. (B) Maintenance doses. Categories of prematurity were defined as follows: birth at ≥37 weeks of amenorrhea (WA), born at term; between ≥32 and &lt;37 WA, moderate to late preterm; between ≥28 and &lt;32 WA, very preterm; between ≥24 and &lt;28 WA, extremely preterm.</p></figcaption></figure></section><section id="s2-2"><h3 class="pmc_sec_title">Vancomycin exposure.</h3>
<p>The repartition of vancomycin Cavg according to the therapeutic range for both groups is presented in <a href="#T2" class="usa-link">Table 2</a>. Initial vancomycin Cavg were more frequently within the therapeutic range for the after group, with a target attainment rate of 74.6% versus 28.3% for the before group (<em>P</em> &lt; 0.001). The initial vancomycin Cavg were 1.6-fold higher for the after than the before group. The time intervals between vancomycin initiation and the first vancomycin Cavg determinations were shorter for the after group (before: 50.1 [47.3–52.5] hours versus after: 26.3 [24.4–37.0] hours, <em>P</em> &lt; 0.001).</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Vancomycin exposure before and after implementation of the vancomycin dose-optimization protocol</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
</colgroup>
<thead>
<tr>
<th rowspan="2" colspan="1">Factor</th>
<th rowspan="1" colspan="1"></th>
<th colspan="2" rowspan="1">Data for:<a href="#T2F1" class="usa-link"><sup><em>a</em></sup></a><hr>
</th>
<th rowspan="2" colspan="1">
<em>P</em> value</th>
</tr>
<tr>
<th rowspan="1" colspan="1"></th>
<th rowspan="1" colspan="1">Before group</th>
<th rowspan="1" colspan="1">After group</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Initial Cavg</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">
<em>n</em> = 60</td>
<td rowspan="1" colspan="1">
<em>n</em> = 59</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Repartition<a href="#T2F2" class="usa-link"><sup><em>b</em></sup></a>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">  Subtherapeutic</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">41 (68.3)</td>
<td rowspan="1" colspan="1">6 (10.2)</td>
<td rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">  Therapeutic</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">17 (28.3)</td>
<td rowspan="1" colspan="1">44 (74.6)</td>
<td rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">  Supra-therapeutic</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">2 (3.3)</td>
<td rowspan="1" colspan="1">9 (15.3)</td>
<td rowspan="1" colspan="1">0.001</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Concentration (mg/L)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">12.9 [11.3–17.0]</td>
<td rowspan="1" colspan="1">20.3 [17.0–22.2]</td>
<td rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">All Cavg</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">
<em>n</em> = 116</td>
<td rowspan="1" colspan="1">
<em>n</em> = 103</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Repartition<a href="#T2F2" class="usa-link"><sup><em>b</em></sup></a>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">  Subtherapeutic</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">78 (67.2)</td>
<td rowspan="1" colspan="1">13 (12.6)</td>
<td rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">  Therapeutic</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">36 (31.0)</td>
<td rowspan="1" colspan="1">77 (74.8)</td>
<td rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">  Supra-therapeutic</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">2 (1.7)</td>
<td rowspan="1" colspan="1">13 (12.6)</td>
<td rowspan="1" colspan="1">0.025</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Concentration (mg/L)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">13.1 [11.3–16.2]</td>
<td rowspan="1" colspan="1">19.8 [16.8–22.1]</td>
<td rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Initial Cavg/MIC ratio</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">
<em>n</em><strong> = </strong>22</td>
<td rowspan="1" colspan="1">
<em>n</em><strong> = </strong>17</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Repartition</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">  &lt;8</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">10 (45.5)</td>
<td rowspan="1" colspan="1">2 (11.8)</td>
<td rowspan="1" colspan="1">0.02</td>
</tr>
<tr>
<td rowspan="1" colspan="1">  ≥8</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">12 (54.5)</td>
<td rowspan="1" colspan="1">15 (88.2)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Cavg/MIC ratio</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">8.8 [6.2–11.5]</td>
<td rowspan="1" colspan="1">12.8 [10.9–20.9]</td>
<td rowspan="1" colspan="1">0.004</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Initial AUC/MIC ratio</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">
<em>n</em>
<strong>=</strong> 22</td>
<td rowspan="1" colspan="1">
<em>n</em>
<strong>=</strong> 17</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Repartition</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">  &lt;400</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">20/22 (90.9)</td>
<td rowspan="1" colspan="1">10/17 (58.8)</td>
<td rowspan="1" colspan="1">0.02</td>
</tr>
<tr>
<td rowspan="1" colspan="1">  ≥400</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">2/22 (9.1)</td>
<td rowspan="1" colspan="1">7/17 (41.2)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> AUC/MIC ratio</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">211 [149–275]</td>
<td rowspan="1" colspan="1">307 [262–502]</td>
<td rowspan="1" colspan="1">0.006</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="T2F1">
<sup>a</sup><p class="display-inline">Data are reported as <em>n</em> (%) or medians [25<sup>th</sup> to 75<sup>th</sup> percentiles].</p>
</div>
<div class="fn" id="T2F2">
<sup>b</sup><p class="display-inline">Therapeutic range, Cavg between 15 and 25 mg/L; subtherapeutic, Cavg &lt; 15 mg/L; supra-therapeutic, Cavg &gt; 25mg/L. Cavg, average concentration; AUC, area under the curve.</p>
</div>
</div></section><p>Considering all vancomycin Cavg obtained during longitudinal TDM, the after group more frequently attained the therapeutic range than the before group, with higher vancomycin Cavg (<a href="#T2" class="usa-link">Table 2</a>). Considering only documented infections, the area under the curve (AUC)/MIC and Cavg/MIC ratios were higher and more often reached the recommended thresholds (&gt;400 for AUC/MIC and &gt;8 for Cavg/MIC) in the after group than the before group (<a href="#T2" class="usa-link">Table 2</a>). The frequency of AUC &gt; 800 mg · h/L and AUC/MIC &gt; 650 was not different between the two groups (data not shown).</p></section><section id="s2-3"><h3 class="pmc_sec_title">Secondary outcomes.</h3>
<p>Results concerning the secondary outcomes are presented in <a href="#T3" class="usa-link">Table 3</a>.</p>
<section class="tw xbox font-sm" id="T3"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Biological and clinical outcomes before and after implementation of the vancomycin dose-optimization protocol</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col span="1">
<col span="1">
<col span="1">
<col span="1">
</colgroup>
<thead>
<tr>
<th rowspan="2" colspan="1">Factor</th>
<th colspan="2" rowspan="1">Data for:<a href="#T3F1" class="usa-link"><sup><em>a</em></sup></a><hr>
</th>
<th rowspan="2" colspan="1">
<em>P</em> value</th>
</tr>
<tr>
<th rowspan="1" colspan="1">Before group</th>
<th rowspan="1" colspan="1">After group</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Antibiotic therapy</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Duration of vancomycin therapy (days)</td>
<td rowspan="1" colspan="1">6 [3–10] (<em>n</em> = 60)</td>
<td rowspan="1" colspan="1">5 [2–9] (<em>n</em> = 58)</td>
<td rowspan="1" colspan="1">0.089</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Antibiotic switch</td>
<td rowspan="1" colspan="1">9/31 (29)</td>
<td rowspan="1" colspan="1">1/22 (4.5)</td>
<td rowspan="1" colspan="1">0.025</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Biological parameters</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Nephrotoxicity<a href="#T3F2" class="usa-link"><sup><em>b</em></sup></a>
</td>
<td rowspan="1" colspan="1">1/59 (1.7)</td>
<td rowspan="1" colspan="1">2/57 (3.5)</td>
<td rowspan="1" colspan="1">0.54</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Time to blood culture negativation (h)</td>
<td rowspan="1" colspan="1">54.6 [48.9–107] (<em>n</em> = 31)</td>
<td rowspan="1" colspan="1">37.5 [28.1–53.6] (<em>n</em> = 22)</td>
<td rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Relapse</td>
<td rowspan="1" colspan="1">3/31 (9.7)</td>
<td rowspan="1" colspan="1">0/22 (0)</td>
<td rowspan="1" colspan="1">0.13</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Decrease of inflammatory syndrome<a href="#T3F3" class="usa-link"><sup><em>c</em></sup></a>
</td>
<td rowspan="1" colspan="1">4/23 (17.4)</td>
<td rowspan="1" colspan="1">8/21 (38.0)</td>
<td rowspan="1" colspan="1">0.12</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Immediate clinical outcomes</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Increased respiratory support<a href="#T3F4" class="usa-link"><sup><em>d</em></sup></a>
</td>
<td rowspan="1" colspan="1">26/60 (43.3)</td>
<td rowspan="1" colspan="1">18/59 (30.5)</td>
<td rowspan="1" colspan="1">0.15</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Duration of vasoactive drugs use (days)</td>
<td rowspan="1" colspan="1">3.5 [1.0–9.0] (<em>n</em> = 18)</td>
<td rowspan="1" colspan="1">1.5 [1.0–5.0] (<em>n</em> = 10)</td>
<td rowspan="1" colspan="1">0.18</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Duration of parenteral nutrition (days)</td>
<td rowspan="1" colspan="1">16 [9–25] (<em>n</em> = 53)</td>
<td rowspan="1" colspan="1">17 [9–29] (<em>n</em> = 49)</td>
<td rowspan="1" colspan="1">0.87</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Duration of insulin therapy (days)</td>
<td rowspan="1" colspan="1">5 [3–7] (<em>n</em> = 9)</td>
<td rowspan="1" colspan="1">4 [2–7.5] (<em>n</em> = 15)</td>
<td rowspan="1" colspan="1">0.81</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Catheter removal</td>
<td rowspan="1" colspan="1">12/31 (38.7)</td>
<td rowspan="1" colspan="1">10/22 (45.5)</td>
<td rowspan="1" colspan="1">0.62</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Consequences on morbidities</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Severe bronchopulmonary dysplasia<a href="#T3F5" class="usa-link"><sup><em>e</em></sup></a>
</td>
<td rowspan="1" colspan="1">10/29 (34.5)</td>
<td rowspan="1" colspan="1">5/34 (14.7)</td>
<td rowspan="1" colspan="1">0.066</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Periventricular leukomalacia<a href="#T3F5" class="usa-link"><sup><em>e</em></sup></a>
</td>
<td rowspan="1" colspan="1">7/31 (22.6)</td>
<td rowspan="1" colspan="1">1/35 (2.9)</td>
<td rowspan="1" colspan="1">0.021</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Total duration of hospitalization (days)</td>
<td rowspan="1" colspan="1">86.5 [46.3–107.0] (<em>n</em> = 36)</td>
<td rowspan="1" colspan="1">86.5 [55.0–123.0] (<em>n</em> = 46)</td>
<td rowspan="1" colspan="1">0.75</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="T3F1">
<sup>a</sup><p class="display-inline">Data are reported as <em>n</em>/total <em>n</em> (%) or medians [25<sup>th</sup> to 75<sup>th</sup> percentiles], with numbers indicated in parenthesis.</p>
</div>
<div class="fn" id="T3F2">
<sup>b</sup><p class="display-inline">Nephrotoxicity defined as either a 2-fold increase or an increase of at least 0.6 mg/dL (or 52.8 μmol/L) of plasma creatinine concentration from baseline at treatment initiation until the end of vancomycin therapy.</p>
</div>
<div class="fn" id="T3F3">
<sup>c</sup><p class="display-inline">Decrease of inflammatory syndrome defined as a decrease of C reactive protein level of at least 10 mg/L between initial measure and the following measured at 24 to 28 h after vancomycin initiation.</p>
</div>
<div class="fn" id="T3F4">
<sup>d</sup><p class="display-inline">Increased respiratory support was defined as switching to continuous positive airway pressure, bi-level positive airway pressure, or mechanical ventilation, or switching to high-frequency oscillatory ventilation.</p>
</div>
<div class="fn" id="T3F5">
<sup>e</sup><p class="display-inline">Severe bronchopulmonary dysplasia and periventricular leucomalacia were evaluated according to the criteria of the National Institute of Child Health workshop (<a href="#B20" class="usa-link" aria-describedby="B20">20</a>, <a href="#B45" class="usa-link" aria-describedby="B45">45</a>) and the de Vries et al. grading system (<a href="#B46" class="usa-link" aria-describedby="B46">46</a>), respectively.</p>
</div>
</div></section><p><strong>(i) Safety of the protocol.</strong> Only one patient showed nephrotoxicity in the before group, and two in the after group, which was not statistically different. The highest Cavg obtained was 12.2 mg/L for the unique patient who developed renal dysfunction in the before group and 72.8 mg/L and 25.4 mg/L for the two patients of the after group. These three patients were also treated with gentamicin, and two (one in the group before, one in the group after) developed anuria immediately after surgical procedures (one emergency surgery for severe acute enterocolitis and one surgery for myelomeningocele).</p>
<p><strong>(ii) Biological parameters.</strong> The after group showed a shorter time to negative blood culture (<em>P</em> &lt; 0.001), even though blood culture frequencies were similar in the two groups (data not shown). Furthermore, the biological inflammatory syndrome decreased more frequently, with fewer relapses, in the after group, although these findings did not reach significance.</p>
<p><strong>(iii) Antibiotic therapy.</strong> Antibiotic switches were significantly less frequent for the after group. The duration of vancomycin therapy also tended to be lower. However, we did not observe this tendency when considering only documented infections due to Gram-positive cocci (before (<em>n</em> = 28): 10.0 [7.75–12.0] days versus after (<em>n</em> = 19): 9.0 [8.0–10.5] days, <em>P</em> = 0.425).</p>
<p><strong>(iv) Immediate clinical outcomes.</strong> The proportion of infants requiring increased ventilatory support, as well as the duration of vasoactive drug use, was smaller for the after group, without reaching statistical significance. There were no differences in terms of the duration of parenteral nutrition, insulin therapy, or the number of catheter removals between the two groups.</p>
<p><strong>(v) Neonatal morbidity.</strong> There were significantly fewer cases of periventricular leukomalacia and a tendency toward fewer cases of severe bronchopulmonary dysplasia in the after group. There were no differences in the length of hospitalization.</p></section></section><section id="s3"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p>This study is the first to demonstrate the utility of model-informed precision dosing of vancomycin administered by continuous infusion in neonates in terms of improved vancomycin exposure and clinical and biological outcomes in clinical practice.</p>
<p>First, vancomycin exposure in the first hours was improved with the vancomycin dose optimization protocol, with a 2.6-fold increase in the proportion of initial Cavg in the therapeutic range. Before implementation of the dose-optimization protocol, only 28.3% of initial vancomycin Cavg were therapeutic, in accordance with results reported in previous studies using various standard dosing regimens (from 25.1 to 41.4%) (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>, <a href="#B5" class="usa-link" aria-describedby="B5">5</a>, <a href="#B7" class="usa-link" aria-describedby="B7">7</a>, <a href="#B8" class="usa-link" aria-describedby="B8">8</a>, <a href="#B17" class="usa-link" aria-describedby="B17">17</a>). The <em>a priori</em> vancomycin dose adjustment allowed us to reach a proportion of 74.6% of initial plasma therapeutic Cavg (measured during vancomycin continuous infusion), very close to the 70.1 and 72% reported in studies using the same pharmacokinetic model and therapeutic range (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>, <a href="#B15" class="usa-link" aria-describedby="B15">15</a>). This finding is all the more in favor of adequate vancomycin exposure in the first hours of treatment with the dose optimization protocol that initial vancomycin Cavg were determined earlier in the group treated under it (i.e., after group) than the group that was not (i.e., before group). The increase in initial vancomycin therapeutic Cavg resulted from an increase in loading and maintenance doses of vancomycin with the dose optimization protocol, these increases being particularly high in extremely preterm neonates (who are the most at risk of infection-induced complications).</p>
<p>Although vancomycin exposure correlates with therapeutic efficacy, it is also necessary to take into account the individual sensitivity of each bacterial strain (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>). We thus evaluated initial AUC/MIC and Cavg/MIC ratios for documented infections and found them to more often reach the recommended thresholds (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>, <a href="#B20" class="usa-link" aria-describedby="B20">20</a>) in the after than the before group. In addition, the vancomycin dose-optimization protocol resulted in an improvement of vancomycin exposure throughout the duration of treatment, with an increase in the proportion of therapeutic Cavg during longitudinal TDM from 31 to 74.8%.</p>
<p>The increase in vancomycin Cavg resulting from the implementation of the dose-optimization protocol did not change the frequency of nephrotoxicity, which was very low for both the before (1/59) and after (2/57) groups. In addition, all neonates that developed nephrotoxicity had at least one additional risk factor of renal function deterioration (aminoside cotreatment and/or surgical procedure). Such findings are in accordance with those of the study of Leroux et al. (<a href="#B15" class="usa-link" aria-describedby="B15">15</a>) and further supports the safety of the vancomycin dose-optimization protocol.</p>
<p>In addition, the improvement of vancomycin exposure was accompanied by an improvement in several biological and microbiological outcomes, with for example, a shorter time to obtaining negative blood cultures and a reduction in the number of antibiotic switches. The reduced duration of bacteremia in neonates with the <em>a priori</em> vancomycin dose adjustment is in accordance with the results of recent studies showing that insufficient vancomycin exposure in the first 48 to 72 h is associated with prolonged bacteremia in children (<a href="#B21" class="usa-link" aria-describedby="B21">21</a>, <a href="#B22" class="usa-link" aria-describedby="B22">22</a>). The clinical response to vancomycin therapy of adult patients with lower respiratory tract infections has also been shown to be better for patients with high vancomycin exposure and rapid bacterial eradication (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>), but similar data for late-onset sepsis in neonates are still lacking. Here, we found that neonates benefiting from the vancomycin dose-optimization protocol tended to have less respiratory instability, a reduced duration of vasoactive drug use, and a greater decrease in inflammatory syndrome during the first 24 to 48 h of therapy, as well as fewer relapses. Although significance was not reached, such tendencies concerning clinical and biological outcomes have never been reported for neonates. A recent prospective comparative study evaluating the impact of an early Bayesian dose-adjustment protocol of vancomycin in children, for example, did not find any differences in terms of the time to obtain apyrexia or the evolution of C reactive protein (CRP) values (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>). However, our results are in accordance with those of the retrospective study of Cardile et al., which showed that optimization of vancomycin exposure in adults through TDM was associated with significant clinical improvement relative to patients without TDM (<a href="#B24" class="usa-link" aria-describedby="B24">24</a>).</p>
<p>Late-onset sepsis has been identified as a risk factor for neonatal morbidity (<a href="#B25" class="usa-link" aria-describedby="B25">25</a><a href="#B26" class="usa-link" aria-describedby="B26">–</a><a href="#B31" class="usa-link" aria-describedby="B31">31</a>). We thus investigated the impact of vancomycin dose optimization on such complications, which has not been studied to date. We found fewer cases of periventricular leukomalacia and a trend toward fewer cases of severe bronchopulmonary dysplasia in patients benefiting from the dose-optimization protocol, without any difference in terms of the length of hospital stay.</p>
<p>This study had several limitations. Aside from its retrospective design, we evaluated vancomycin exposure through Cavg, for which there is no consensus in terms of the therapeutic range (<a href="#B17" class="usa-link" aria-describedby="B17">17</a>, <a href="#B32" class="usa-link" aria-describedby="B32">32</a><a href="#B33" class="usa-link" aria-describedby="B33">–</a><a href="#B34" class="usa-link" aria-describedby="B34">34</a>), whereas the unbound Cavg (<a href="#B35" class="usa-link" aria-describedby="B35">35</a>) (or unbound AUC and AUC/MIC) (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>) would have been better parameters. In addition, interference leading to underestimation of the vancomycin concentration with IgM levels of &gt;15 mg/L was reported for the PETINIA technique on the Vista device (<a href="#B36" class="usa-link" aria-describedby="B36">36</a>). As we used this method until June 2019, we cannot exclude that vancomycin Cavg for some neonates in the before group were underestimated due to such interference. However, IgM levels in neonates, especially premature infants, are low (<a href="#B37" class="usa-link" aria-describedby="B37">37</a>) and would have been unlikely to interfere with vancomycin quantification by PETINIA. Finally, although our findings concerning the clinical benefits of vancomycin dose optimization are very promising, they must be interpreted with caution. Indeed, both groups included neonates for whom the suspicion of sepsis was not confirmed by blood culture (47.5 and 60% of courses in the before and after groups, respectively). Moreover, concerning neonatal morbidities, all risk factors for periventricular leukomalacia (for example, intrauterine infection or early-onset sepsis) (<a href="#B38" class="usa-link" aria-describedby="B38">38</a>, <a href="#B39" class="usa-link" aria-describedby="B39">39</a>) and broncho-pulmonary dysplasia (chorioamnionitis, Apgar score, surfactant, postnatal steroids, treatment for patent ductus arteriosus) (<a href="#B26" class="usa-link" aria-describedby="B26">26</a>, <a href="#B29" class="usa-link" aria-describedby="B29">29</a>) were not taken into account.</p>
<section id="s3-1"><h3 class="pmc_sec_title">Conclusion.</h3>
<p>Our study demonstrates that the vancomycin dose-optimization protocol increases vancomycin exposure in neonates and is associated with a significant improvement in biological and clinical outcomes, with good safety in terms of nephrotoxicity. Further prospective studies conducted on larger populations are expected to confirm the clinical benefits of optimized dosing regimens for vancomycin in neonates (<a href="#B14" class="usa-link" aria-describedby="B14">14</a>), before their generalization in all neonatal units.</p></section></section><section id="s4"><h2 class="pmc_sec_title">MATERIALS AND METHODS</h2>
<section id="s4-1"><h3 class="pmc_sec_title">Study design.</h3>
<p>This comparative, retrospective, single-center study was conducted in the neonatal intensive care unit of the Grenoble Alpes University Hospital in France. A protocol of vancomycin dose optimization was implemented in routine care in September 2019. Neonates treated with vancomycin as a continuous infusion before or after its implementation between 1 August 2018, and 31 October 2020, were included in groups before or after implementation (see flow chart in <a href="#F1" class="usa-link">Fig. 1</a>). Vancomycin therapy was started in cases of suspicion of neonatal sepsis due to clinical instability and/or altered biological parameters. The duration of vancomycin therapy was left to the discretion of the clinician according to clinical evolution and the results of blood cultures.</p>
<p>Inclusion criteria were neonates treated with vancomycin with at least one determination of vancomycin Cavg during this period. Exclusion criteria were children for whom their legal representatives objected to the use of their medical data, vancomycin treatment initiated in another center, a nonstandard dose of vancomycin for meningitis in the before group, and the vancomycin dose-optimization protocol not used for the after group.</p>
<p>Biological (plasma creatinine and CRP levels, vancomycin Cavg, blood culture) and clinical (type of respiratory support, use of vasoactive drugs, parenteral nutrition and insulin therapy, catheter removal, presence of bronchopulmonary dysplasia and periventricular leukomalacia, and hospitalization length) data were retrospectively collected from medical records (see “Secondary Objectives,” below, for more details), while MIC of bacteria isolated from blood culture (and stored at room temperature) were measured specifically for research.</p>
<p>This noninterventional study involving data and samples from human participants was carried out according to the Declaration of Helsinki and current French regulations. The investigator (Elodie Gautier-Veyret, Pharm.D., Ph.D.) has signed a commitment to comply with Reference Methodology no. 004 issued by the French authorities Commission Nationale de l'Informatique et des Libertés (CNIL). Participants were all informed and did not object. Written consent for participation was not required for this study, in accordance with national legislation and institutional requirements.</p>
<p>The raw data supporting the conclusions of this study will be made available by the authors according to General Data Protection Regulations, without undue reservation. Ethical approval for the study was obtained on 1 September 2021 (CECIC Rhone-Alpes-Auvergne, Clermont-Ferrand, Institutional Review Board [IRB] 5891).</p></section><section id="s4-2"><h3 class="pmc_sec_title">Vancomycin dose optimization protocol.</h3>
<p>The protocol of vancomycin dose optimization consists of the individualization of initial vancomycin doses (both loading and maintenance doses) through a previously validated pharmacokinetic model (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>) and further dose adjustment following TDM, when needed. Initial doses were calculated by neonatologists using an Excel file (see Fig. S1), with formulas previously proposed by Zhao et al. (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>). These formulas derived from a one-compartment pharmacokinetic model are based on weights at birth and at treatment initiation, plasma creatinine level, and postnatal age (see Fig. S1 for details). The first vancomycin Cavg measurement was then performed at 24 h, with the therapeutic range for vancomycin Cavg being between 15 and 25 mg/L (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>). Dose adjustments were proposed in the reports of the biological analyses in the event of out-of-range vancomycin Cavg (&lt;15 mg/L or &gt;25 mg/L). The target Cavg used for dose calculations was 20 mg/L.</p>
<p>The empirical vancomycin dosing regimen before the implementation of this protocol, based on the corrected gestational age (<a href="#B32" class="usa-link" aria-describedby="B32">32</a>), is described in Table S1. Before September 2019, the first vancomycin Cavg measurement was performed approximatively 48 h after vancomycin treatment initiation. A similar therapeutic range was recommended in our institution during this period, but no specific dose adjustment was recommended.</p>
<p>After the first vancomycin Cavg measurement, the frequency of the following vancomycin measurements (i.e., longitudinal TDM) was left to the discretion of the clinician for both periods (before and after implementation of the protocol of vancomycin dose optimization).</p>
<p>For both periods, loading doses were administered through a 1-h infusion followed immediately by continuous infusion of maintenance doses.</p></section><section id="s4-3"><h3 class="pmc_sec_title">Vancomycin therapeutic drug monitoring.</h3>
<p>Plasma vancomycin concentrations were measured at steady state in a clinical laboratory using a commercial immunometric assay during routine care. A Dimension Vista system (Siemens Healthcare Diagnostics, Saint Denis, France) device with a particle-enhanced turbidimetric inhibition immunoassay (PETINIA) was used until June 2019 (range of concentrations, 0.8 to 50 mg/L), from which time a chemiluminescence-based method on an Architect (Abbott laboratories, Rungis, France) system was used to quantify vancomycin (range of concentrations, 3 to 100 mg/L). Before this change, the correlation between these two methods was verified on 39 samples, with a good coefficient of correlation (r<sup>2</sup> = 0.9942) and a slope near 1 (0.918). The within- and between-day accuracy and precision of both methods fulfilled Food and Drug Administration validation criteria.</p></section><section id="s4-4"><h3 class="pmc_sec_title">Objectives.</h3>
<p><strong>(i) Main objective.</strong> The main objective of this study was to compare the proportion of initial vancomycin Cavg in the therapeutic range before and after the implementation of this protocol. The primary endpoint was the percentage of initial vancomycin Cavg in the therapeutic range.</p>
<p><strong>(ii) Secondary objectives.</strong> The secondary objectives were to evaluate the impact of this vancomycin dose-optimization protocol on various biological and clinical outcomes assessed during routine care.</p>
<p>Vancomycin-induced nephrotoxicity, MICs, initial vancomycin Cavg/MIC and AUC/MIC ratios, duration of vancomycin therapy, number of antibiotic switches due to lack of efficacy of vancomycin (excluding antibiotic deescalation), duration of bacteremia, rate of relapse, evolution of biological inflammatory syndrome, and rate of catheter removal were assessed. In addition, classically unstable clinical parameters in sepsis (<a href="#B25" class="usa-link" aria-describedby="B25">25</a><a href="#B26" class="usa-link" aria-describedby="B26">–</a><a href="#B27" class="usa-link" aria-describedby="B27">27</a>, <a href="#B40" class="usa-link" aria-describedby="B40">40</a><a href="#B41" class="usa-link" aria-describedby="B41">–</a><a href="#B42" class="usa-link" aria-describedby="B42">42</a>) (rate of increased respiratory support, duration of vasoactive drug use, parenteral nutrition, insulin therapy were all evaluated from vancomycin initiation), as well as neonatal morbidities associated with infections (<a href="#B25" class="usa-link" aria-describedby="B25">25</a><a href="#B26" class="usa-link" aria-describedby="B26">–</a><a href="#B31" class="usa-link" aria-describedby="B31">31</a>, <a href="#B43" class="usa-link" aria-describedby="B43">43</a>) (bronchopulmonary dysplasia, periventricular leukomalacia, total duration of hospitalization until discharge) were studied.</p>
<p>Nephrotoxicity was defined as either a 2-fold increase or an increase of at least 0.6 mg/dL (or 52.8 μmol/L) of plasma creatinine concentration from baseline at treatment initiation until the end of vancomycin therapy (<a href="#B44" class="usa-link" aria-describedby="B44">44</a>). Creatinine concentrations were determined in a clinical laboratory, using an enzymatic method on an Atellica device (Siemens Healthcare Diagnostics, Saint Denis, France).</p>
<p>In the event of a documented bloodstream bacterial infection due to Gram-positive cocci, the MIC of vancomycin against bacteria isolated from blood cultures was measured by broth microdilution using vancomycin/teicoplanin MIC strips (UMIC; Biocentric, Bandol, France) in a clinical laboratory. Vancomycin Cavg/MIC and AUC/MIC ratios were calculated, with respective thresholds of ≥8 (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>, <a href="#B19" class="usa-link" aria-describedby="B19">19</a>) and 400 (<a href="#B20" class="usa-link" aria-describedby="B20">20</a>).</p>
<p>The duration of bacteremia was assessed by calculating the time between vancomycin initiation and the first negative blood culture. Relapses were defined as a recurrent positive blood culture with the same pathogen (same species with similar antibiogram) (<a href="#B45" class="usa-link" aria-describedby="B45">45</a>) within 7 days after obtaining a negative blood culture. The latter two criteria were only assessed in children with a positive blood culture.</p>
<p>Evolution of the biological inflammatory syndrome was assessed by the evolution of CRP within the first 24 to 48 h of treatment in patients with an initial CRP value of &gt;10 mg/L. A decrease of inflammatory syndrome was defined as a decrease of at least 10 mg/L of the CRP value between the initial measure at the initiation of vancomycin and the following measure after 24 to 48 h of treatment.</p>
<p>The frequency of biological analysis (CRP measurement, blood culture and plasma creatinine measurement) was left to the discretion of the neonatologist.</p>
<p>The respiratory status was assessed by the increase in ventilatory support during vancomycin therapy, i.e., switching to continuous positive airway pressure, bi-level positive airway pressure, or mechanical ventilation and switching to high-frequency oscillatory ventilation for patients already intubated and ventilated. The presence of severe bronchopulmonary dysplasia and periventricular leukomalacia was recorded at the time of discharge from hospital according to criteria of the National Institute of Child Health workshop (<a href="#B46" class="usa-link" aria-describedby="B46">46</a>, <a href="#B47" class="usa-link" aria-describedby="B47">47</a>) and the de Vries et al. grading system (<a href="#B48" class="usa-link" aria-describedby="B48">48</a>), respectively.</p></section><section id="s4-5"><h3 class="pmc_sec_title">Statistical analysis.</h3>
<p>The sample size required to show a doubling of the proportion of initial vancomycin therapeutic concentration with 80% power and a two-sided alpha risk of 0.05 was 59 courses of treatment for each group (assuming a proportion of 30% of initial vancomycin therapeutic Cavg). This calculation was performed using G*Power software (version 3.1.9.7; Heinrich-Heine-University, Germany). Data are reported as medians (25<sup>th</sup> to 75<sup>th</sup> percentiles) or <em>n</em> (%). Chi-square (or Fischer) and Mann-Whitney tests were used. A <em>P</em> value of 0.05 was considered statistically significant. All statistical analyses were performed using Jamovi software (version 1.2.27).</p></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">ACKNOWLEDGMENTS</h2>
<p>We thank Florentia Kaguelidou and Valérie Biran for their advice on implementation of the vancomycin dose-optimization protocol.</p>
<p>This work was not supported by any funding, as the data were generated as part of routine practice.</p>
<p>We declare no conflict of interest.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn12">
<p>Supplemental material is available online only.</p>
<div class="p">
<section class="sm xbox font-sm" id="SuF1"><div class="caption p">
<span>Supplemental file 1</span><div class="p">Table S1 and Fig. S1 and S2. Download <a href="/articles/instance/9112885/bin/aac.02191-21-s0001.pdf" class="usa-link" id="SF1">aac.02191-21-s0001.pdf, PDF file, 0.2 MB</a><sup> (237.3KB, pdf) </sup>
</div>
</div></section>
</div>
</div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>Jacqz-Aigrain E, Zhao W, Sharland M, van den Anker JN. 2013. Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration. Semin Fetal Neonatal Med
18:28–34. 10.1016/j.siny.2012.10.003.</cite> [<a href="https://doi.org/10.1016/j.siny.2012.10.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23137927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Semin%20Fetal%20Neonatal%20Med&amp;title=Use%20of%20antibacterial%20agents%20in%20the%20neonate:%2050%20years%20of%20experience%20with%20vancomycin%20administration&amp;volume=18&amp;publication_year=2013&amp;pages=28-34&amp;pmid=23137927&amp;doi=10.1016/j.siny.2012.10.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>Isaacs D. 2003. A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Arch Dis Child Fetal Neonatal Ed
88:F89–F93. 10.1136/fn.88.2.F89.</cite> [<a href="https://doi.org/10.1136/fn.88.2.F89" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1721527/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12598493/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Dis%20Child%20Fetal%20Neonatal%20Ed&amp;title=A%20ten%20year,%20multicentre%20study%20of%20coagulase%20negative%20staphylococcal%20infections%20in%20Australasian%20neonatal%20units&amp;volume=88&amp;publication_year=2003&amp;pages=F89-F93&amp;pmid=12598493&amp;doi=10.1136/fn.88.2.F89&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H, ARPEC Project Group. 2016. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother
71:1106–1117. 10.1093/jac/dkv418.</cite> [<a href="https://doi.org/10.1093/jac/dkv418" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26747104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Antimicrob%20Chemother&amp;title=The%20Worldwide%20Antibiotic%20Resistance%20and%20Prescribing%20in%20European%20Children%20(ARPEC)%20point%20prevalence%20survey:%20developing%20hospital-quality%20indicators%20of%20antibiotic%20prescribing%20for%20children&amp;volume=71&amp;publication_year=2016&amp;pages=1106-1117&amp;pmid=26747104&amp;doi=10.1093/jac/dkv418&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>Zhao W, Lopez E, Biran V, Durrmeyer X, Fakhoury M, Jacqz-Aigrain E. 2013. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring. Arch Dis Child
98:449–453. 10.1136/archdischild-2012-302765.</cite> [<a href="https://doi.org/10.1136/archdischild-2012-302765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23254142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Dis%20Child&amp;title=Vancomycin%20continuous%20infusion%20in%20neonates:%20dosing%20optimisation%20and%20therapeutic%20drug%20monitoring&amp;volume=98&amp;publication_year=2013&amp;pages=449-453&amp;pmid=23254142&amp;doi=10.1136/archdischild-2012-302765&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>Sinkeler FS, de Haan TR, Hodiamont CJ, Bijleveld YA, Pajkrt D, Mathôt RAA. 2014. Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations. BMC Pediatr
14:193. 10.1186/1471-2431-14-193.</cite> [<a href="https://doi.org/10.1186/1471-2431-14-193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4124772/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25066951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Pediatr&amp;title=Inadequate%20vancomycin%20therapy%20in%20term%20and%20preterm%20neonates:%20a%20retrospective%20analysis%20of%20trough%20serum%20concentrations%20in%20relation%20to%20minimal%20inhibitory%20concentrations&amp;volume=14&amp;publication_year=2014&amp;pages=193&amp;pmid=25066951&amp;doi=10.1186/1471-2431-14-193&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>Padari H, Oselin K, Tasa T, Metsvaht T, Lõivukene K, Lutsar I. 2016. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
BMC Pediatr
16:206. 10.1186/s12887-016-0753-0.</cite> [<a href="https://doi.org/10.1186/s12887-016-0753-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5146818/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27931193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Pediatr&amp;title=Coagulase%20negative%20staphylococcal%20sepsis%20in%20neonates:%20do%20we%20need%20to%20adapt%20vancomycin%20dose%20or%20target?&amp;volume=16&amp;publication_year=2016&amp;pages=206&amp;pmid=27931193&amp;doi=10.1186/s12887-016-0753-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>Sosnin N, Curtis N, Cranswick N, Chiletti R, Gwee A. 2019. Vancomycin is commonly under-dosed in critically ill children and neonates. Br J Clin Pharmacol
85:2591–2598. 10.1111/bcp.14084.</cite> [<a href="https://doi.org/10.1111/bcp.14084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6848905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31378957/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&amp;title=Vancomycin%20is%20commonly%20under-dosed%20in%20critically%20ill%20children%20and%20neonates&amp;volume=85&amp;publication_year=2019&amp;pages=2591-2598&amp;pmid=31378957&amp;doi=10.1111/bcp.14084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>Ringenberg T, Robinson C, Meyers R, Degnan L, Shah P, Siu A, Sturgill M. 2015. Achievement of therapeutic vancomycin trough serum concentrations with empiric dosing in neonatal intensive care unit patients. Pediatr Infect Dis J
34:742–747. 10.1097/INF.0000000000000664.</cite> [<a href="https://doi.org/10.1097/INF.0000000000000664" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25629890/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr%20Infect%20Dis%20J&amp;title=Achievement%20of%20therapeutic%20vancomycin%20trough%20serum%20concentrations%20with%20empiric%20dosing%20in%20neonatal%20intensive%20care%20unit%20patients&amp;volume=34&amp;publication_year=2015&amp;pages=742-747&amp;pmid=25629890&amp;doi=10.1097/INF.0000000000000664&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>Abdulla A, Edwina AE, Flint RB, Allegaert K, Wildschut ED, Koch BCP, de Hoog M. 2021. Model-informed precision dosing of antibiotics in pediatric patients: a narrative review. Front Pediatr
9:624639. 10.3389/fped.2021.624639.</cite> [<a href="https://doi.org/10.3389/fped.2021.624639" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7940353/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33708753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pediatr&amp;title=Model-informed%20precision%20dosing%20of%20antibiotics%20in%20pediatric%20patients:%20a%20narrative%20review&amp;volume=9&amp;publication_year=2021&amp;pages=624639&amp;pmid=33708753&amp;doi=10.3389/fped.2021.624639&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>Frymoyer A, Hersh AL, El-Komy MH, Gaskari S, Su F, Drover DR, Van Meurs K. 2014. Association between vancomycin trough concentration and area under the concentration-time curve in neonates. Antimicrob Agents Chemother
58:6454–6461. 10.1128/AAC.03620-14.</cite> [<a href="https://doi.org/10.1128/AAC.03620-14" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4249374/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25136027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob%20Agents%20Chemother&amp;title=Association%20between%20vancomycin%20trough%20concentration%20and%20area%20under%20the%20concentration-time%20curve%20in%20neonates&amp;volume=58&amp;publication_year=2014&amp;pages=6454-6461&amp;pmid=25136027&amp;doi=10.1128/AAC.03620-14&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>Hughes DM, Goswami S, Keizer RJ, Hughes M-SA, Faldasz JD. 2020. Bayesian clinical decision support-guided versus clinician-guided vancomycin dosing in attainment of targeted pharmacokinetic parameters in a paediatric population. J Antimicrob Chemother
75:434–437. 10.1093/jac/dkz444.</cite> [<a href="https://doi.org/10.1093/jac/dkz444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31670812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Antimicrob%20Chemother&amp;title=Bayesian%20clinical%20decision%20support-guided%20versus%20clinician-guided%20vancomycin%20dosing%20in%20attainment%20of%20targeted%20pharmacokinetic%20parameters%20in%20a%20paediatric%20population&amp;volume=75&amp;publication_year=2020&amp;pages=434-437&amp;pmid=31670812&amp;doi=10.1093/jac/dkz444&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>Dao K, Guidi M, André P, Giannoni E, Basterrechea S, Zhao W, Fuchs A, Pfister M, Buclin T, Csajka C. 2020. Optimisation of vancomycin exposure in neonates based on the best level of evidence. Pharmacol Res
154:104278. 10.1016/j.phrs.2019.104278.</cite> [<a href="https://doi.org/10.1016/j.phrs.2019.104278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31108184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol%20Res&amp;title=Optimisation%20of%20vancomycin%20exposure%20in%20neonates%20based%20on%20the%20best%20level%20of%20evidence&amp;volume=154&amp;publication_year=2020&amp;pages=104278&amp;pmid=31108184&amp;doi=10.1016/j.phrs.2019.104278&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>Berthaud R, Benaboud S, Hirt D, Genuini M, Oualha M, Castelle M, Briand C, Artru S, Norsa L, Boyer O, Foissac F, Bouazza N, Tréluyer J-M. 2019. Early Bayesian dose adjustment of vancomycin continuous infusion in children in a randomized controlled trial. Antimicrob Agents Chemother
63:10. 10.1128/AAC.01102-19.</cite> [<a href="https://doi.org/10.1128/AAC.01102-19" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6879247/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31591117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob%20Agents%20Chemother&amp;title=Early%20Bayesian%20dose%20adjustment%20of%20vancomycin%20continuous%20infusion%20in%20children%20in%20a%20randomized%20controlled%20trial&amp;volume=63&amp;publication_year=2019&amp;pages=10&amp;pmid=31591117&amp;doi=10.1128/AAC.01102-19&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>Hill LF, Turner MA, Lutsar I, Heath PT, Hardy P, Linsell L, Jacqz-Aigrain E, Roilides E, Sharland M, NeoVanc Consortium. 2020. An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial. Trials
21:329. 10.1186/s13063-020-4184-8.</cite> [<a href="https://doi.org/10.1186/s13063-020-4184-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7158076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32293527/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trials&amp;title=An%20optimised%20dosing%20regimen%20versus%20a%20standard%20dosing%20regimen%20of%20vancomycin%20for%20the%20treatment%20of%20late%20onset%20sepsis%20due%20to%20Gram-positive%20microorganisms%20in%20neonates%20and%20infants%20aged%20less%20than%2090%E2%80%89days%20(NeoVanc):%20study%20protocol%20for%20a%20randomised%20controlled%20trial&amp;volume=21&amp;publication_year=2020&amp;pages=329&amp;pmid=32293527&amp;doi=10.1186/s13063-020-4184-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>Leroux S, Jacqz-Aigrain E, Biran V, Lopez E, Madeleneau D, Wallon C, Zana-Taïeb E, Virlouvet A-L, Rioualen S, Zhao W. 2016. Clinical utility and safety of a model-based patient-tailored dose of vancomycin in neonates. Antimicrob Agents Chemother
60:2039–2042. 10.1128/AAC.02214-15.</cite> [<a href="https://doi.org/10.1128/AAC.02214-15" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4808207/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26787690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob%20Agents%20Chemother&amp;title=Clinical%20utility%20and%20safety%20of%20a%20model-based%20patient-tailored%20dose%20of%20vancomycin%20in%20neonates&amp;volume=60&amp;publication_year=2016&amp;pages=2039-2042&amp;pmid=26787690&amp;doi=10.1128/AAC.02214-15&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>Frymoyer A, Schwenk HT, Zorn Y, Bio L, Moss JD, Chasmawala B, Faulkenberry J, Goswami S, Keizer RJ, Ghaskari S. 2020. Model-informed precision dosing of vancomycin in hospitalized children: implementation and adoption at an academic children’s hospital. Front Pharmacol
11:551. 10.3389/fphar.2020.00551.</cite> [<a href="https://doi.org/10.3389/fphar.2020.00551" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7201037/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32411000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Model-informed%20precision%20dosing%20of%20vancomycin%20in%20hospitalized%20children:%20implementation%20and%20adoption%20at%20an%20academic%20children%E2%80%99s%20hospital&amp;volume=11&amp;publication_year=2020&amp;pages=551&amp;pmid=32411000&amp;doi=10.3389/fphar.2020.00551&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>Tauzin M, Cohen R, Durrmeyer X, Dassieu G, Barre J, Caeymaex L. 2019. Continuous-infusion vancomycin in neonates: assessment of a dosing regimen and therapeutic proposal. Front Pediatr. 7:188. 10.3389/fped.2019.00188.</cite> [<a href="https://doi.org/10.3389/fped.2019.00188" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6527807/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31139607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pediatr&amp;title=Continuous-infusion%20vancomycin%20in%20neonates:%20assessment%20of%20a%20dosing%20regimen%20and%20therapeutic%20proposal&amp;volume=7&amp;publication_year=2019&amp;pages=188&amp;pmid=31139607&amp;doi=10.3389/fped.2019.00188&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>Asín-Prieto E, Rodríguez-Gascón A, Isla A. 2015. Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents. J Infect Chemother
21:319–329. 10.1016/j.jiac.2015.02.001.</cite> [<a href="https://doi.org/10.1016/j.jiac.2015.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25737147/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Infect%20Chemother&amp;title=Applications%20of%20the%20pharmacokinetic/pharmacodynamic%20(PK/PD)%20analysis%20of%20antimicrobial%20agents&amp;volume=21&amp;publication_year=2015&amp;pages=319-329&amp;pmid=25737147&amp;doi=10.1016/j.jiac.2015.02.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>Daurel C, Leclercq R. 2010. Vancomycin, what else?
Arch Pediatr
17:S121–S128. (In French). 10.1016/S0929-693X(10)70912-X.</cite> [<a href="https://doi.org/10.1016/S0929-693X(10)70912-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20826319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Pediatr&amp;title=Vancomycin,%20what%20else?&amp;volume=17&amp;publication_year=2010&amp;pages=S121-S128&amp;pmid=20826319&amp;doi=10.1016/S0929-693X(10)70912-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro B. 2020. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis
71:1361–1364. 10.1093/cid/ciaa303.</cite> [<a href="https://doi.org/10.1093/cid/ciaa303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32658968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=Therapeutic%20monitoring%20of%20vancomycin%20for%20serious%20methicillin-resistant%20Staphylococcus%20aureus%20infections:%20a%20revised%20consensus%20guideline%20and%20review%20by%20the%20American%20Society%20of%20Health-system%20Pharmacists,%20the%20Infectious%20Diseases%20Society%20of%20America,%20the%20Pediatric%20Infectious%20Diseases%20Society,%20and%20the%20Society%20of%20Infectious%20Diseases%20Pharmacists&amp;volume=71&amp;publication_year=2020&amp;pages=1361-1364&amp;pmid=32658968&amp;doi=10.1093/cid/ciaa303&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>Hsu AJ, Hamdy RF, Huang Y, Olson JA, Ghobrial S, Gerber JS, Hersh AL, Tamma PD. 2018. Association between vancomycin trough concentrations and duration of methicillin-resistant Staphylococcus aureus bacteremia in children. J Pediatr Infect Dis Soc
7:338–341. 10.1093/jpids/pix068.</cite> [<a href="https://doi.org/10.1093/jpids/pix068" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28992126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pediatr%20Infect%20Dis%20Soc&amp;title=Association%20between%20vancomycin%20trough%20concentrations%20and%20duration%20of%20methicillin-resistant%20Staphylococcus%20aureus%20bacteremia%20in%20children&amp;volume=7&amp;publication_year=2018&amp;pages=338-341&amp;pmid=28992126&amp;doi=10.1093/jpids/pix068&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>Yoo R, So H, Seo E, Kim M, Lee J. 2021. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children. PLoS One
16:e0247714. 10.1371/journal.pone.0247714.</cite> [<a href="https://doi.org/10.1371/journal.pone.0247714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8016336/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33793589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Impact%20of%20initial%20vancomycin%20pharmacokinetic/pharmacodynamic%20parameters%20on%20the%20clinical%20and%20microbiological%20outcomes%20of%20methicillin-resistant%20Staphylococcus%20aureus%20bacteremia%20in%20children&amp;volume=16&amp;publication_year=2021&amp;pages=e0247714&amp;pmid=33793589&amp;doi=10.1371/journal.pone.0247714&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. 2004. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet
43:925–942. 10.2165/00003088-200443130-00005.</cite> [<a href="https://doi.org/10.2165/00003088-200443130-00005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15509186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacokinet&amp;title=Pharmacodynamics%20of%20vancomycin%20and%20other%20antimicrobials%20in%20patients%20with%20Staphylococcus%20aureus%20lower%20respiratory%20tract%20infections&amp;volume=43&amp;publication_year=2004&amp;pages=925-942&amp;pmid=15509186&amp;doi=10.2165/00003088-200443130-00005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>Cardile AP, Tan C, Lustik MB, Stratton AN, Madar CS, Elegino J, Hsue G. 2015. Optimization of time to initial vancomycin target trough improves clinical outcomes. SpringerPlus
4:364. 10.1186/s40064-015-1146-9.</cite> [<a href="https://doi.org/10.1186/s40064-015-1146-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4506278/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26203410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=SpringerPlus&amp;title=Optimization%20of%20time%20to%20initial%20vancomycin%20target%20trough%20improves%20clinical%20outcomes&amp;volume=4&amp;publication_year=2015&amp;pages=364&amp;pmid=26203410&amp;doi=10.1186/s40064-015-1146-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>Jiang S, Yang Z, Shan R, Zhang Y, Yan W, Yang Y, Shah PS, Lee SK, Cao Y. 2020. Neonatal outcomes following culture-negative late-onset sepsis among preterm infants. Pediatr Infect Dis J
39:232–238. 10.1097/INF.0000000000002558.</cite> [<a href="https://doi.org/10.1097/INF.0000000000002558" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32032307/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr%20Infect%20Dis%20J&amp;title=Neonatal%20outcomes%20following%20culture-negative%20late-onset%20sepsis%20among%20preterm%20infants&amp;volume=39&amp;publication_year=2020&amp;pages=232-238&amp;pmid=32032307&amp;doi=10.1097/INF.0000000000002558&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>Ebrahimi ME, Romijn M, Vliegenthart RJS, Visser DH, van Kaam AH, Onland W. 2021. The association between clinical and biochemical characteristics of late-onset sepsis and bronchopulmonary dysplasia in preterm infants. Eur J Pediatr
180:2147–2154. 10.1007/s00431-021-03981-9.</cite> [<a href="https://doi.org/10.1007/s00431-021-03981-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7904512/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33629121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Pediatr&amp;title=The%20association%20between%20clinical%20and%20biochemical%20characteristics%20of%20late-onset%20sepsis%20and%20bronchopulmonary%20dysplasia%20in%20preterm%20infants&amp;volume=180&amp;publication_year=2021&amp;pages=2147-2154&amp;pmid=33629121&amp;doi=10.1007/s00431-021-03981-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>Bury G, Leroux S, Leon Borrego C, Leguen CG, Mitanchez D, Gascoin G, Thollot A, Roué JM, Carrault G, Pladys P, Beuchée A. 2021. Diagnosis of neonatal late-onset infection in very preterm infant: inter-observer agreement and international classifications. Int J Environ Res Public Health
18:882. 10.3390/ijerph18030882.</cite> [<a href="https://doi.org/10.3390/ijerph18030882" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7908350/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33498557/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Environ%20Res%20Public%20Health&amp;title=Diagnosis%20of%20neonatal%20late-onset%20infection%20in%20very%20preterm%20infant:%20inter-observer%20agreement%20and%20international%20classifications&amp;volume=18&amp;publication_year=2021&amp;pages=882&amp;pmid=33498557&amp;doi=10.3390/ijerph18030882&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, Fanaroff AA, Lemons JA, Donovan EF, Oh W, Stevenson DK, Ehrenkranz RA, Papile L-A, Verter J, Wright LL. 1996. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr
129:63–71. 10.1016/S0022-3476(96)70191-9.</cite> [<a href="https://doi.org/10.1016/S0022-3476(96)70191-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8757564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pediatr&amp;title=Late-onset%20sepsis%20in%20very%20low%20birth%20weight%20neonates:%20a%20report%20from%20the%20National%20Institute%20of%20Child%20Health%20and%20Human%20Development%20Neonatal%20Research%20Network&amp;volume=129&amp;publication_year=1996&amp;pages=63-71&amp;pmid=8757564&amp;doi=10.1016/S0022-3476(96)70191-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>Jung E, Lee BS. 2019. Late-onset sepsis as a risk factor for bronchopulmonary dysplasia in extremely low birth weight infants: a nationwide cohort study. Sci Rep
9:15448. 10.1038/s41598-019-51617-8.</cite> [<a href="https://doi.org/10.1038/s41598-019-51617-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6820783/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31664055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Late-onset%20sepsis%20as%20a%20risk%20factor%20for%20bronchopulmonary%20dysplasia%20in%20extremely%20low%20birth%20weight%20infants:%20a%20nationwide%20cohort%20study&amp;volume=9&amp;publication_year=2019&amp;pages=15448&amp;pmid=31664055&amp;doi=10.1038/s41598-019-51617-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>Ohlin A, Björkman L, Serenius F, Schollin J, Källén K. 2015. Sepsis as a risk factor for neonatal morbidity in extremely preterm infants. Acta Paediatr
104:1070–1076. 10.1111/apa.13104.</cite> [<a href="https://doi.org/10.1111/apa.13104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26118325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Paediatr&amp;title=Sepsis%20as%20a%20risk%20factor%20for%20neonatal%20morbidity%20in%20extremely%20preterm%20infants&amp;volume=104&amp;publication_year=2015&amp;pages=1070-1076&amp;pmid=26118325&amp;doi=10.1111/apa.13104&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>Volpe JJ. 2008. Postnatal sepsis, necrotizing entercolitis, and the critical role of systemic inflammation in white matter injury in premature infants. J Pediatr
153:160–163. 10.1016/j.jpeds.2008.04.057.</cite> [<a href="https://doi.org/10.1016/j.jpeds.2008.04.057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2593633/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18639727/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pediatr&amp;title=Postnatal%20sepsis,%20necrotizing%20entercolitis,%20and%20the%20critical%20role%20of%20systemic%20inflammation%20in%20white%20matter%20injury%20in%20premature%20infants&amp;volume=153&amp;publication_year=2008&amp;pages=160-163&amp;pmid=18639727&amp;doi=10.1016/j.jpeds.2008.04.057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>Pawlotsky F, Thomas A, Kergueris MF, Debillon T, Roze JC. 1998. Constant rate infusion of vancomycin in premature neonates: a new dosage schedule. Br J Clin Pharmacol
46:163–167. 10.1046/j.1365-2125.1998.00763.x.</cite> [<a href="https://doi.org/10.1046/j.1365-2125.1998.00763.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1873667/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9723826/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&amp;title=Constant%20rate%20infusion%20of%20vancomycin%20in%20premature%20neonates:%20a%20new%20dosage%20schedule&amp;volume=46&amp;publication_year=1998&amp;pages=163-167&amp;pmid=9723826&amp;doi=10.1046/j.1365-2125.1998.00763.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>Tseng S-H, Lim CP, Chen Q, Tang CC, Kong ST, Ho PC-L. 2018. Evaluating the relationship between vancomycin trough concentration and 24-hour area under the concentration-time curve in neonates. Antimicrob Agents Chemother
62:e01647-17. 10.1128/AAC.01647-17.</cite> [<a href="https://doi.org/10.1128/AAC.01647-17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5914004/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29358290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob%20Agents%20Chemother&amp;title=Evaluating%20the%20relationship%20between%20vancomycin%20trough%20concentration%20and%2024-hour%20area%20under%20the%20concentration-time%20curve%20in%20neonates&amp;volume=62&amp;publication_year=2018&amp;pages=e01647-17&amp;pmid=29358290&amp;doi=10.1128/AAC.01647-17&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>Oudin C, Vialet R, Boulamery A, Martin C, Simon N. 2011. Vancomycin prescription in neonates and young infants: toward a simplified dosage. Arch Dis Child Fetal Neonatal Ed
96:F365–70. 10.1136/adc.2010.196402.</cite> [<a href="https://doi.org/10.1136/adc.2010.196402" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21378399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Dis%20Child%20Fetal%20Neonatal%20Ed&amp;title=Vancomycin%20prescription%20in%20neonates%20and%20young%20infants:%20toward%20a%20simplified%20dosage&amp;volume=96&amp;publication_year=2011&amp;pages=F365-70&amp;pmid=21378399&amp;doi=10.1136/adc.2010.196402&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>Smits A, Pauwels S, Oyaert M, Peersman N, Spriet I, Saegeman V, Allegaert K. 2018. Factors impacting unbound vancomycin concentrations in neonates and young infants. Eur J Clin Microbiol Infect Dis
37:1503–1510. 10.1007/s10096-018-3277-8.</cite> [<a href="https://doi.org/10.1007/s10096-018-3277-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29770901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Clin%20Microbiol%20Infect%20Dis&amp;title=Factors%20impacting%20unbound%20vancomycin%20concentrations%20in%20neonates%20and%20young%20infants&amp;volume=37&amp;publication_year=2018&amp;pages=1503-1510&amp;pmid=29770901&amp;doi=10.1007/s10096-018-3277-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>LeGatt DF, Blakney GB, Higgins TN, Schnabl KL, Shalapay CE, Dias VC, Wesenberg JC. 2012. The effect of paraproteins and rheumatoid factor on four commercial immunoassays for vancomycin: implications for laboratorians and other health care professionals. Ther Drug Monit
34:306–311. 10.1097/FTD.0b013e318257335f.</cite> [<a href="https://doi.org/10.1097/FTD.0b013e318257335f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22569352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ther%20Drug%20Monit&amp;title=The%20effect%20of%20paraproteins%20and%20rheumatoid%20factor%20on%20four%20commercial%20immunoassays%20for%20vancomycin:%20implications%20for%20laboratorians%20and%20other%20health%20care%20professionals&amp;volume=34&amp;publication_year=2012&amp;pages=306-311&amp;pmid=22569352&amp;doi=10.1097/FTD.0b013e318257335f&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>Alkan Ozdemir S, Ozer EA, Kose S, Ilhan O, Ozturk C, Sutcuoglu S. 2016. Reference values of serum IgG and IgM levels in preterm and term newborns. J Matern Fetal Neonatal Med
29:972–976. 10.3109/14767058.2015.1027680.</cite> [<a href="https://doi.org/10.3109/14767058.2015.1027680" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25845271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Matern%20Fetal%20Neonatal%20Med&amp;title=Reference%20values%20of%20serum%20IgG%20and%20IgM%20levels%20in%20preterm%20and%20term%20newborns&amp;volume=29&amp;publication_year=2016&amp;pages=972-976&amp;pmid=25845271&amp;doi=10.3109/14767058.2015.1027680&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>Resch B, Neubauer K, Hofer N, Resch E, Maurer U, Haas J, Müller W. 2012. Episodes of hypocarbia and early-onset sepsis are risk factors for cystic periventricular leukomalacia in the preterm infant. Early Hum Dev
88:27–31. 10.1016/j.earlhumdev.2011.06.011.</cite> [<a href="https://doi.org/10.1016/j.earlhumdev.2011.06.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21752559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Early%20Hum%20Dev&amp;title=Episodes%20of%20hypocarbia%20and%20early-onset%20sepsis%20are%20risk%20factors%20for%20cystic%20periventricular%20leukomalacia%20in%20the%20preterm%20infant&amp;volume=88&amp;publication_year=2012&amp;pages=27-31&amp;pmid=21752559&amp;doi=10.1016/j.earlhumdev.2011.06.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>Romero-Guzman GJ, Lopez-Munoz F. 2017. Prevalence and risk factors for periventricular leukomalacia in preterm infants. A systematic review. Rev Neurol
65:57–62. (In Spanish).</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/28675256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rev%20Neurol&amp;title=Prevalence%20and%20risk%20factors%20for%20periventricular%20leukomalacia%20in%20preterm%20infants.%20A%20systematic%20review&amp;volume=65&amp;publication_year=2017&amp;pages=57-62&amp;pmid=28675256&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>Zea-Vera A, Ochoa TJ. 2015. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr
61:1–13. 10.1093/tropej/fmu079.</cite> [<a href="https://doi.org/10.1093/tropej/fmu079" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4375388/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25604489/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Trop%20Pediatr&amp;title=Challenges%20in%20the%20diagnosis%20and%20management%20of%20neonatal%20sepsis&amp;volume=61&amp;publication_year=2015&amp;pages=1-13&amp;pmid=25604489&amp;doi=10.1093/tropej/fmu079&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<span class="label">41.</span><cite>Davis AL, Carcillo JA, Aneja RK, Deymann AJ, Lin JC, Nguyen TC, Okhuysen-Cawley RS, Relvas MS, Rozenfeld RA, Skippen PW, Stojadinovic BJ, Williams EA, Yeh TS, Balamuth F, Brierley J, de Caen AR, Cheifetz IM, Choong K, Conway E, Cornell T, Doctor A, Dugas M-A, Feldman JD, Fitzgerald JC, Flori HR, Fortenberry JD, Graciano AL, Greenwald BM, Hall MW, Han YY, Hernan LJ, Irazuzta JE, Iselin E, van der Jagt EW, Jeffries HE, Kache S, Katyal C, Kissoon N, Kon AA, Kutko MC, MacLaren G, Maul T, Mehta R, Odetola F, Parbuoni K, Paul R, Peters MJ, Ranjit S, Reuter-Rice KE, Schnitzler EJ, et al. 2017. American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med
45:1061–1093. 10.1097/CCM.0000000000002425.</cite> [<a href="https://doi.org/10.1097/CCM.0000000000002425" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28509730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care%20Med&amp;title=American%20College%20of%20Critical%20Care%20Medicine%20clinical%20practice%20parameters%20for%20hemodynamic%20support%20of%20pediatric%20and%20neonatal%20septic%20shock&amp;volume=45&amp;publication_year=2017&amp;pages=1061-1093&amp;pmid=28509730&amp;doi=10.1097/CCM.0000000000002425&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<span class="label">42.</span><cite>Hirasawa H, Oda S, Nakamura M. 2009. Blood glucose control in patients with severe sepsis and septic shock. World J Gastroenterol
15:4132–4136. 10.3748/wjg.15.4132.</cite> [<a href="https://doi.org/10.3748/wjg.15.4132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2738808/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19725146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20J%20Gastroenterol&amp;title=Blood%20glucose%20control%20in%20patients%20with%20severe%20sepsis%20and%20septic%20shock&amp;volume=15&amp;publication_year=2009&amp;pages=4132-4136&amp;pmid=19725146&amp;doi=10.3748/wjg.15.4132&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<span class="label">43.</span><cite>Dong Y, Speer CP, Glaser K. 2018. Beyond sepsis: Staphylococcus epidermidis is an underestimated but significant contributor to neonatal morbidity. Virulence
9:621–633. 10.1080/21505594.2017.1419117.</cite> [<a href="https://doi.org/10.1080/21505594.2017.1419117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5955464/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29405832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Virulence&amp;title=Beyond%20sepsis:%20Staphylococcus%20epidermidis%20is%20an%20underestimated%20but%20significant%20contributor%20to%20neonatal%20morbidity&amp;volume=9&amp;publication_year=2018&amp;pages=621-633&amp;pmid=29405832&amp;doi=10.1080/21505594.2017.1419117&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<span class="label">44.</span><cite>Bhatt-Mehta V, Schumacher RE, Faix RG, Leady M, Brenner T. 1999. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study. Pediatrics
103:e48. 10.1542/peds.103.4.e48.</cite> [<a href="https://doi.org/10.1542/peds.103.4.e48" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10103340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics&amp;title=Lack%20of%20vancomycin-associated%20nephrotoxicity%20in%20newborn%20infants:%20a%20case-control%20study&amp;volume=103&amp;publication_year=1999&amp;pages=e48&amp;pmid=10103340&amp;doi=10.1542/peds.103.4.e48&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<span class="label">45.</span><cite>Kim T, Lee SC, Kim MJ, Jung J, Sung H, Kim M-N, Kim S-H, Lee S-O, Choi S-H, Woo JH, Kim YS, Chong YP. 2020. Clinical significance of follow-up blood culture in patients with a single <em>Staphylococcus aureus</em>-positive blood culture. Infect Dis (Lond)
52:207–212. 10.1080/23744235.2019.1701198.</cite> [<a href="https://doi.org/10.1080/23744235.2019.1701198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31833431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Infect%20Dis%20(Lond)&amp;title=Clinical%20significance%20of%20follow-up%20blood%20culture%20in%20patients%20with%20a%20single%20Staphylococcus%20aureus-positive%20blood%20culture&amp;volume=52&amp;publication_year=2020&amp;pages=207-212&amp;pmid=31833431&amp;doi=10.1080/23744235.2019.1701198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<span class="label">46.</span><cite>Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K, for the National Institutes of Child Health and Human Development Neonatal Research Network. 2005. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics
116:1353–1360. 10.1542/peds.2005-0249.</cite> [<a href="https://doi.org/10.1542/peds.2005-0249" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16322158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics&amp;title=Validation%20of%20the%20National%20Institutes%20of%20Health%20consensus%20definition%20of%20bronchopulmonary%20dysplasia&amp;volume=116&amp;publication_year=2005&amp;pages=1353-1360&amp;pmid=16322158&amp;doi=10.1542/peds.2005-0249&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<span class="label">47.</span><cite>Jobe AH, Bancalari E. 2001. Bronchopulmonary dysplasia. Am J Respir Crit Care Med
163:1723–1729. 10.1164/ajrccm.163.7.2011060.</cite> [<a href="https://doi.org/10.1164/ajrccm.163.7.2011060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11401896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Respir%20Crit%20Care%20Med&amp;title=Bronchopulmonary%20dysplasia&amp;volume=163&amp;publication_year=2001&amp;pages=1723-1729&amp;pmid=11401896&amp;doi=10.1164/ajrccm.163.7.2011060&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<span class="label">48.</span><cite>de Vries LS, Eken P, Dubowitz LMS. 1992. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res
49:1–6. 10.1016/S0166-4328(05)80189-5.</cite> [<a href="https://doi.org/10.1016/S0166-4328(05)80189-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1388792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Behav%20Brain%20Res&amp;title=The%20spectrum%20of%20leukomalacia%20using%20cranial%20ultrasound&amp;volume=49&amp;publication_year=1992&amp;pages=1-6&amp;pmid=1388792&amp;doi=10.1016/S0166-4328(05)80189-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>Supplemental file 1</span><p>Table S1 and Fig. S1 and S2. Download <a href="/articles/instance/9112885/bin/aac.02191-21-s0001.pdf" class="usa-link">aac.02191-21-s0001.pdf, PDF file, 0.2 MB</a><sup> (237.3KB, pdf) </sup></p>
</div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of <strong>American Society for Microbiology (ASM)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1128/aac.02191-21"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/aac.02191-21.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (651.0 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9112885/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9112885/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9112885%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9112885/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9112885/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9112885/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/35465728/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9112885/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/35465728/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9112885/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9112885/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="13MVsqyjwepFrMVEfZywJzh3jfimkPmmxL5S9g8LAA0lNl9sBfw8OWxZT0qdaNj0">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
